| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cel-Sci Corporation (CVM) has 6 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. CVM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 222.5K | $231.4K | - | |
| VP | 38.0K | $39.5K | - | |
| Dir | 28.0K | $29.1K | - | |
| Dir | 27.3K | $28.4K | - | |
| CFO | 12.0K | $12.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | Baillavoine Bruno Jean-Marie | Director | Buy | 1,250 | $8.00 | $10,000.00 | +26.5% | +36.5% | -45.4% | |
| Jun 28, 2021 | Young Peter R | Director | Buy | 3,000 | $12.66 | $37,971.00 | +11.6% | -10.7% | -67.5% | |
| Apr 22, 2021 | Cipriano John | Senior Vice President | Sell | 10,000 | $24.38 | $243,793.00 | -13.7% | -66.5% | -88.2% | |
| Dec 11, 2020 | Young Peter R | Director | Buy | 100 | $14.24 | $1,424.00 | +0.4% | - | - | |
| Nov 18, 2020 | Watson Robert Eugene | Director | Buy | 800 | $11.77 | $9,416.00 | +33.6% | - | - | |
| Nov 18, 2020 | Baillavoine Bruno Jean-Marie | Director | Buy | 800 | $11.77 | $9,416.00 | +20.4% | - | - | |
| Nov 17, 2020 | Young Peter R | Director | Buy | 800 | $11.68 | $9,343.20 | +3.2% | - | - | |
| Nov 13, 2020 | Cipriano John | Senior Vice President | Sell | 10,000 | $12.73 | $127,290.00 | -12.0% | - | - | |
| Nov 4, 2020 | Young Peter R | Director | Buy | 3,000 | $11.35 | $34,060.00 | +6.7% | - | - | |
| Feb 26, 2020 | Zimmerman Daniel H | Senior Vice President | Buy | 923 | $10.83 | $9,996.09 | +0.8% | - | - |